Price T Rowe Associates Inc Opti Nose, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Opti Nose, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 18,651 shares of OPTN stock, worth $19,397. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,651
Previous 17,505
6.55%
Holding current value
$19,397
Previous $23,000
21.74%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding OPTN
# of Institutions
73Shares Held
59.6MCall Options Held
0Put Options Held
0-
Mvm Partners, LLC Boston, MA14.6MShares$15.2 Million12.71% of portfolio
-
Great Point Partners LLC Greenwich, CT8.79MShares$9.14 Million3.14% of portfolio
-
Black Rock Inc. New York, NY4.28MShares$4.45 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.24MShares$4.41 Million0.0% of portfolio
-
Bleichroeder LP New York, NY4.05MShares$4.21 Million1.83% of portfolio
About OptiNose, Inc.
- Ticker OPTN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 83,277,504
- Market Cap $86.6M
- Description
- OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...